5 Best Short Squeeze Stocks To Buy Now

3. Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)

Year to Date Share Price Performance: 22.39%

Float Short: 21.01%

Number of Hedge Fund Investors In Q4 2023: 34

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is an American company developing cancer treatments. It’s one of the top rated stocks on our list, as the shares are rated Strong Buy on average and analysts have set an average share price target of $20.50.

By the end of last year’s fourth quarter, 34 out of the 933 hedge funds polled by Insider Monkey had invested in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA). Michael Rachesky’s MHR Fund Management was the largest stakeholder due to its $162 million stake.

Follow Iovance Biotherapeutics Inc. (NASDAQ:IOVA)